1. Anti-SARS-CoV-2 antibody immunoreactivity profiles during COVID-19 recurrence
- Author
-
Maria da Penha Gomes Gouvea, Isac Ribeiro Moulaz, Thayná Martins Gouveia, Karen Evelin Monlevade Lança, Bárbara Sthefany de Paula Lacerda, Beatriz Paoli Thompson, Jéssica Polese, Marina Deorce de Lima, Rodrigo Ribeiro-Rodrigues, José Geraldo Mill, and Valéria Valim
- Subjects
COVID-19 ,SARS-CoV-2 ,Recurrence ,Humoral Reactivity ,Arctic medicine. Tropical medicine ,RC955-962 - Abstract
ABSTRACT Background: This study aimed to evaluate IgG and IgM levels in COVID-19 recurrence. Methods: The serum antibody levels and clinical data from 73 healthcare workers with SARS-CoV-2 divided into seroconverted (n=51) and non-seroconverted (n=22) groups were assessed. The presence of specific anti-nucleocapsid (anti-N) IgM and IgG for SARS-CoV-2 was evaluated. IgG antibodies to the SARS-CoV-2 spike receptor-binding domain were used to confirm non-seroconversion in all negative anti-N. Results: Four recurrent cases displayed mild symptoms and were non-seroconverted until the recurrence of symptoms. Conclusions: Undetectable anti-nucleocapsid IgM and IgG levels may be correlated with symptomatic COVID-19 recurrence.
- Published
- 2022
- Full Text
- View/download PDF